ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

11,047Medicare Part D Prescriptions Filled, Including Refills

Rank: 102 out of 973

$434K Total Retail Price of All Prescriptions

Rank: 201 out of 973

379 Patients Receiving at Least One Drug in Part D
85%Patients 65 Years and Older
30% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Kansas
Lower avg

Schedule Two
Controlled Substances

8% of this provider’s 379 patients filled at least one prescription for a schedule two drug, compared to an average of 6%.

Schedule Three
Controlled Substances

17% of this provider’s 379 patients filled at least one prescription for a schedule three drug, compared to an average of 14%.

Risky Drugs to Seniors

3% of this provider’s 9,747 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

17% of this provider’s prescriptions were for brand-name drugs, compared to an average of 22%.

Prescription Price

$39 was the average price of a prescription from this provider, compared to $51 among peers.

Prescriptions per Patient

29 is the average number of prescriptions (including refills) per patient, compared to an average of 21.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Kansas
SIMVASTATIN 664 592 1 1
OMEPRAZOLE 452 412 2 5
FUROSEMIDE 435 391 3 6
LEVOTHYROXINE SODIUM 351 326 4 2
METFORMIN HCL 338 294 5 8
POTASSIUM CHLORIDE 338 297 5 9
LISINOPRIL 327 283 7 3
METOPROLOL TARTRATE 250 240 8 13
HYDROCODONE-ACETAMINOPHEN 245 194 S3 9 4
WARFARIN SODIUM 236 236 10 10
LISINOPRIL-HYDROCHLOROTHIAZIDE 213 197 11 25
AMLODIPINE BESYLATE 211 194 12 7
GABAPENTIN 206 177 13 12
METOPROLOL SUCCINATE 175 172 14 17
ATORVASTATIN CALCIUM 167 138 15 15
HYDROCHLOROTHIAZIDE 162 145 16 11
CITALOPRAM HBR 154 142 17 14
ATENOLOL 136 124 18 16
LOSARTAN POTASSIUM 123 123 19 19
POLYETHYLENE GLYCOL 3350 119 106 20 36
OXYBUTYNIN CHLORIDE 111 92 21 92
PANTOPRAZOLE SODIUM 104 93 22 37
LOSARTAN-HYDROCHLOROTHIAZIDE 102 97 23 46
ZOLPIDEM TARTRATE 99 94 24 20
GLIMEPIRIDE 98 97 25 41
TRIAMTERENE-HCTZ 96 84 26 51
NEXIUM 91 84 27 30
PREDNISONE 90 61 28 33
NAMENDA 89 81 29 31
SERTRALINE HCL 87 65 30 21
DIGOXIN 87 87 30 32
ALLOPURINOL 80 79 32 29
LEVOFLOXACIN 79 59 33 84
ADVAIR DISKUS 79 60 33 60
GLIPIZIDE 75 75 35 69
AZITHROMYCIN 72 57 36 47
PROAIR HFA 69 61 37 54
VERAPAMIL ER 67 67 38 111
SPIRONOLACTONE 66 54 39 49
CYCLOBENZAPRINE HCL 65 44 R 40 42
ENALAPRIL MALEATE 65 64 40 55
SULFAMETHOXAZOLE-TRIMETHOPRIM 64 52 42 76
AMITRIPTYLINE HCL 62 59 R 43 52
ALENDRONATE SODIUM 62 49 43 24
VENLAFAXINE HCL ER 61 48 45 95
RISPERIDONE 60 60 46 65
SUCRALFATE 58 44 47 131
GLYBURIDE 55 44 R 48 59
FENOFIBRATE 55 55 48 77
CLOPIDOGREL 53 51 50 44
NOVOLOG FLEXPEN 51 28 51 168
OXYCODONE-ACETAMINOPHEN 51 50 S2 51 89
CLONIDINE HCL 51 51 51 67
FLUOXETINE HCL 50 18 54 56
LANTUS SOLOSTAR 50 37 54 99
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Nov. 30, 2009.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.